On the27th of March, India delivered 1,00,000 doses of the India made Novel Coronavirus or COVID-19 vaccine doses.
The two vaccines, Covisheild and COVAXIN are manufactured by the Serum Institute of India (SII) and the Hyderabad based Bharat Biotech International Limited, respectively.
An official close to the development, who wished to be anonymous confirmed the delivery of the 1,00,000 doses. A flight of Air India carrying the vaccines is likely to land at Kathmandu.
The arrival of the vaccine, however, hangs on the weather condition of Nepal, as dense smog was spotted in the Nepali airspace.
This is the second delivery of the two India manufactured vaccines to Nepal. Earlier this month, Nepal received 3,48,000 doses of COVID-19 vaccines under the COVAX initiative.
Under the COVAX allocation, the COVAX facility will deliver 1.92 million vaccine doses to Nepal by the end of May 2021, in support of the Government of Nepal’s nationwide vaccination campaign.
Stay tuned for further updates.
